Graham Johnson
Direktor/Vorstandsmitglied bei Shimoda Resources Holdings, Inc.
Profil
Graham Johnson is currently a Director at Shimoda Resources Holdings, Inc. He previously worked as an Interim Vice President-Neuroscience Biology at Bristol Myers Squibb Co. and held the position of Senior VP-Preclinical Development & Research at Sarepta Therapeutics, Inc. from 2010 to 2011.
He also worked as a Principal at Parke-Davis & Co. Ltd.
and as the Chief Research Officer at Melinta Subsidiary Corp.
Dr. Johnson received his undergraduate and doctorate degrees from Heriot-Watt University.
Aktive Positionen von Graham Johnson
| Unternehmen | Position | Beginn |
|---|---|---|
Shimoda Resources Holdings, Inc.
 Shimoda Resources Holdings, Inc. Investment Trusts/Mutual FundsMiscellaneous Shimoda Resources Holdings, Inc. operates as a investment holding company in natural resources sector. The company is headquartered in Wilton, CT. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Graham Johnson
| Unternehmen | Position | Ende |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 13.05.2011 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Corporate Officer/Principal | - |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Graham Johnson
| Heriot-Watt University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Health Technology |
Shimoda Resources Holdings, Inc.
Shimoda Resources Holdings, Inc. Investment Trusts/Mutual FundsMiscellaneous Shimoda Resources Holdings, Inc. operates as a investment holding company in natural resources sector. The company is headquartered in Wilton, CT. | Miscellaneous |